`
` Pages 1 - 137
`
`UNITED STATES DISTRICT COURT
`
`NORTHERN DISTRICT OF CALIFORNIA
`
`BEFORE THE HONORABLE WILLIAM H. ALSUP, JUDGE
`
`FINJAN, INC., )
` )
` Plaintiff, )
` )
` VS. ) NO. C 17-5659 WHA
` )
`JUNIPER NETWORKS, INC., )
` ) San Francisco, California
` Defendant. )
` )
`___________________________________)
`
` Tuesday, December 4, 2018
`
`TRANSCRIPT OF PROCEEDINGS
`
`APPEARANCES:
`
`For Plaintiff:
` KRAMER LEVIN NAFTALIS & FRANKEL, LLP
` 990 Marsh Road
` Menlo Park, California 94025
` BY: PAUL ANDRE, ESQ.
` LISA KOBIALKA, ESQ.
` AUSTIN MANES, ESQ.
` YURIDIA CAIRE, ESQ.
` KRISTOPHER B. KASTENS, ESQ.
`
`For Defendant:
`
` IRELL & MANELLA, LLP
` 840 Newport Center Drive
` Suite 400
` Newport Beach, California 92660
` BY: REBECCA L. CARSON, ESQ.
` KEVIN X. WANG, ESQ.
`
`Reported By: BELLE BALL, CSR 8785, CRR, RDR
` Official Reporter, U.S. District Court
`
`(Appearances continued, next page)
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 2 of 138
`
`APPEARANCES, CONTINUED:
`
`For Defendant:
` IRELL & MANELLA, LLP
` 1800 Avenue of the Stars
` Suite 900
` Los Angeles, California 90024
` BY: JONATHAN S. KAGAN, ESQ.
` CASEY M. CURRAN, ESQ.
` ALAN HEINRICH, ESQ.
` SHARON SONG, ESQ.
` JOSHUA GLUCOFT, ESQ.
`
`Also Present: JULIE ANN MAR-SPINOLA
` ANN TAYLOR
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 3 of 138
`
` 3
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`Tuesday - December 4, 2018
`
` 9:02 a.m.
`
`P R O C E E D I N G S
`
`THE CLERK: Calling Civil Action, 17-5659, Finjan
`
`Inc. versus Juniper Networks, Inc.
`
`Counsel, please step forward and state your appearances
`
`for the record.
`
`THE COURT: Good morning.
`
`MR. ANDRE: Good morning, Your Honor. Paul Andre for
`
`Finjan. And I have my client representatives here today,
`
`Julie Mar-Spinola and Ann Taylor in the back (Indicating).
`
`And with me -- they're back there (Indicating).
`
`THE COURT: Okay. Welcome to all of you.
`
`MR. ANDRE: And I would introduce the attorneys, if
`
`that's okay.
`
`THE COURT: Sure.
`
`MR. ANDRE: Kristopher Kastens, Austin Manes, Lisa
`
`Kobialka and Cristina Martinez.
`
`THE COURT: Thank you.
`
`Welcome to all of you.
`
`MR. ANDRE: Thank you, Your Honor.
`
`MR. KAGAN: Good morning, Your Honor. Jonathan Kagan
`
`of Irell & Manella for Juniper Networks. And with me are
`
`Rebecca Carson --
`
`MS. CARSON: Good morning.
`
`THE COURT: Alan Heinrich.
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 4 of 138
`
` 4
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`MR. HEINRICH: Good morning.
`
`MR. KAGAN: Kevin Wang, Casey Curran, Sharon Song and
`
`Josh Glucoft.
`
`THE COURT: Welcome to all of you.
`
`MR. KAGAN: Thank you, Your Honor.
`
`THE COURT: We are here for a final pretrial
`
`conference for a trial that starts on Monday. And, just jump
`
`right in.
`
`So we have a jury selection process -- ready?
`
`MR. KAGAN: Your Honor, there's one issue we thought
`
`we might raise as a preliminary matter with your -- it relates
`
`to a filing that Finjan made last night.
`
`THE COURT: I haven't seen it.
`
`MR. KAGAN: So --
`
`THE COURT: Did we look? I thought we looked.
`
`THE LAW CLERK: Yeah.
`
`THE COURT: Was there any filing?
`
`THE LAW CLERK: Witness lists, exhibits --
`
`THE COURT: I didn't see, I don't know anything about
`
`it. So what is the issue?
`
`MR. KAGAN: So the issue is we understood from the
`
`Court's ruling yesterday that plaintiffs' damages expert
`
`Mr. Arst would be excluded, based on the Daubert ruling.
`
`And we received -- and we thought the process would then
`
`be the parties would try to streamline their witness list to
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 5 of 138
`
` 5
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`remove witnesses that were no longer necessary in order to
`
`relate to Mr. Arst's testimony and his theory.
`
`But when we got the amended witness list from Finjan, it
`
`included Mr. Arst again, notwithstanding that the Court had
`
`excluded all of his testimony.
`
`And so we'd asked -- I asked last night when we received
`
`this: What portions of Mr. Arst's testimony do you think
`
`survive?
`
`I never got a response from Finjan on that. They simply
`
`filed the list.
`
`So I guess the -- as a preliminary, as a preliminary
`
`matter maybe we should take up that because I think it would
`
`affect the scope of the case. But also, we would certainly at
`
`this point, given the positions they have taken and the fact
`
`they refuse to disclose to us what they intend to put on as a
`
`damages case, we request a formal offer of proof on what their
`
`damages case will look like, in light of this Court's Daubert
`
`order.
`
`THE COURT: All right. That's your position.
`
`What do you have to say, Mister --
`
`MR. ANDRE: Your Honor, we amended the witness list
`
`based on a deposition we took of Mr. Icasiano, a defendant
`
`witness that was disclosed light and subject to these MILs.
`
`And we amended it conditionally that if he's not excluded,
`
`that we designate his deposition and the exhibits that were
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 6 of 138
`
` 6
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`used in his deposition, which was just taken last week. We
`
`just got the transcript in.
`
`So we amended the witness list before the pretrial
`
`conference --
`
`THE COURT: Can somebody hand this thing up to me?
`
`My law clerk didn't give it to me.
`
`Did you give it to me? I don't remember seeing this.
`
`THE LAW CLERK: (Inaudible)
`
`MR. KAGAN: Your Honor, with regard to the issue of
`
`Mr. Icasiano, given the Court's Daubert order, we agreed to
`
`withdraw him. This is a moot issue. He was relevant only to
`
`rebut the damages theory that has now been excluded.
`
`(Document handed up to the Court)
`
`MR. KAGAN: And we informed Finjan of this as well.
`
`There is a motion in limine to exclude Mr. Icasiano's
`
`testimony. In light of the Daubert, we -- there's no reason
`
`to oppose it. We're withdrawing him.
`
`(Reporter interruption)
`
`THE COURT: I don't even see his name on this list.
`
`MR. ANDRE: It should be at the bottom, Your Honor.
`
`By deposition only.
`
`THE COURT: It says Philip Hartstein.
`
`MR. ANDRE: Probably on the back. It's probably
`
`two-sided, Your Honor.
`
`THE COURT: Oh, I see.
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 7 of 138
`
` 7
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`MR. ANDRE: I'm sorry.
`
`(The Court examines document)
`
`THE COURT: Well, the -- the Court's Daubert order
`
`did exclude Arst. So --
`
`MR. ANDRE: Your Honor, with respect to Mr. Arst, you
`
`his cost savings opinion. We would still like to offer him
`
`into testimony to provide issues he did not address like the
`
`Georgia-Pacific factors. He can give him the jury a framework
`
`that they can use to determine a reasonable royalty.
`
`So it -- it's not uncommon to have an expert get up and
`
`not give an opinion as to what damages will be, but to give the
`
`jury a framework they can use to determine a reasonable
`
`royalty.
`
`So we would still propose that Mr. Arst would testify to
`
`that limited extent, you didn't address it in your Daubert, you
`
`said that his cost savings model where he gave a 60- to $70
`
`million figure was unreliable due to the size of it, based on
`
`the revenues. But the rest of his opinion, which he goes and
`
`talks about how one decides a reasonable royalty, for example,
`
`hypothetical negotiation, where the parties are sitting, all
`
`that kind of stuff, I think that's still in the case. You
`
`didn't address that. And I think that would be beneficial to
`
`the jury to get that framework in our case-in-chief. But he
`
`would not give the opinion.
`
`THE COURT: What do you say on that?
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 8 of 138
`
` 8
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`MR. KAGAN: Well, to the extent you're talking about
`
`the framework, that's got to be a subject for jury
`
`instructions. You don't need the expert to come in and
`
`explain what the framework is.
`
`What -- what they're trying do now is to use Mr. Arst to
`
`give essentially not the framework, but their opinion on how
`
`the framework should be implemented. And on that point, we'd
`
`just like to know that in Mr. Arst's opinion, he essentially
`
`said the hypothetical framework doesn't make sense, which is
`
`why he chose his cost approach. So this was a framework that
`
`he essentially injected.
`
`So for example, in his report, he said (As read):
`
`"Finjan's historical licensing practices were derived
`
`from historical jury verdicts, and they have no
`
`reason to assume or conclude that would apply to
`
`Juniper in this case."
`
`And there's numerous examples of this throughout his
`
`report. So what he did was the very framework that they now
`
`want to introduce through Mr. Arst is exactly what he rejected
`
`in his report in favor of this cost statements analysis.
`
`And I would suggest that that is simply not right. They
`
`took their chance with Mr. Arst. They chose not to have him
`
`apply a traditional royalty analysis and instead, they want to
`
`swing for the fences but they struck out. They don't get to
`
`come back now and say: Okay, now let's let him bring up this
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 9 of 138
`
` 9
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`other theory that he never really introduced. And there's
`
`nothing in Court's order that would support that. His
`
`testimony is excluded. He is considered to be an unreliable
`
`expert.
`
`MR. ANDRE: May I address that, Your Honor?
`
`THE COURT: Sure.
`
`MR. ANDRE: Okay. I disagree. He's not an
`
`unreliable expert. His opinion as to the cost savings was
`
`unreliable (sic). His qualifications as an expert are
`
`impeccable. As far as the Georgia-Pacific analysis, he
`
`actually has several pages in his report, starting on Page 45,
`
`where he goes through each one of the Georgia-Pacific factors,
`
`and just says this is a framework --
`
`THE COURT: Give me the paragraph numbers in his
`
`report that you believe are not affected by the Court's
`
`Daubert order, and that you still think could -- may be
`
`coherent testimony before the jury. Give it to me by
`
`paragraph number.
`
`MR. ANDRE: Your Honor, unfortunately they're not
`
`numbered paragraphs or pages. And they have section numbers.
`
`I can give that to you, that's acceptable.
`
`THE COURT: All right. Give it to me in that format.
`
`MR. ANDRE: Okay. So first is Page 4, Section 6.1,
`
`where he talks about Finjan and who they are, and how they
`
`handle their negotiations. 6.1.1 on Page 7, it's Finjan's
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 10 of 138
`
` 10
`
`licensed technology.
`
`THE COURT: I'm sorry. Wait, wait. I've got Page 4,
`
`6.1. Then what?
`
`MR. ANDRE: Page 7, 6.1.1.
`
`THE COURT: All right.
`
`MR. ANDRE: And then Page 12, 6.1.2.
`
`THE COURT: Okay, then what?
`
`MR. ANDRE: Then Page 15, 6.1.3.
`
`(Off-the-Record discussion between counsel)
`
`MR. ANDRE: Page 18, 6.2. Page 19, 6.3 and 6.3.1.
`
`(Off-the-Record discussion)
`
`MR. ANDRE: Page 27, 6.4.
`
`THE COURT: Does 6.3.1 go all the way to 27?
`
`MR. ANDRE: No. I think there's a section there that
`
`would probably be very close to what you excluded. There's
`
`overlaps, so I don't want to run the risk of overlapping
`
`anywhere.
`
`So 6.3.1 ends on Page --
`
`THE COURT: All right. So just -- I'm going to
`
`just -- the section numbers are the key parts. All right.
`
`MR. ANDRE: Yeah.
`
`THE COURT: And then what else?
`
`MR. ANDRE: 6.4, which is the timeline of events. In
`
`Section 7 he talks about the reasonable royalty damages.
`
`THE COURT: Wait a minute. What goes there?
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 11 of 138
`
` 11
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`MR. ANDRE: Page 27, Section 7.
`
`(Off-the-Record discussion between counsel)
`
`MR. ANDRE: He talks about the statute of the
`
`reasonable royalty. And the hypothetical negotiation, the
`
`framework.
`
`THE COURT: I'm not saying yes yet, but tell me what
`
`you think can be salvaged.
`
`MR. ANDRE: Section 29, 7.1, the date of the parties
`
`to the hypothetical negotiation. Section 7.2 on Page 29, and
`
`7.3 on Page 30.
`
`Excluded several of this stuff. And then you get to
`
`Georgia-Pacific factors. First of all, the -- the income
`
`approach on 7.3.3 on Page 44.
`
`THE COURT: 7.3.3?
`
`MR. ANDRE: Uh-huh.
`
`THE COURT: On Page 34?
`
`MR. ANDRE: Page 44. And on Page 45, Section 7.5,
`
`that's the Georgia-Pacific analysis, and that goes for several
`
`pages, up to Page 52.
`
`THE COURT: Is that it?
`
`MR. ANDRE: That's it, Your Honor.
`
`THE COURT: So I don't have an answer for you on
`
`this.
`
`What does the other side say?
`
`MR. KAGAN: So there are two points, Your Honor. The
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 12 of 138
`
` 12
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`first is that although Mr. Arst did mention the
`
`Georgia-Pacific factors in his opinion, he said that they had
`
`zero influence or neutral influence on his opinion.
`
`Specifically, if you look in Section 7.5, which is where
`
`he discusses the Georgia-Pacific analysis, he says (As read):
`
`"In determining a reasonable royalty for Juniper's
`
`alleged use of the '494 patent, I've undertaken an
`
`assessment of the 15 factors set forth in the
`
`Georgia-Pacific case."
`
`He then says -- I'm going skip -- he says:
`
`"For this reason, the Georgia-Pacific factors are
`
`frequently used by my peers who evaluate damages in
`
`the context of commercial litigation. However, it is
`
`important to bear in mind that the relative weight
`
`and importance of the factors can and do vary from
`
`case to case."
`
`And he then stated, towards the end that section:
`
`"As I previously discussed, I've concluded that the
`
`cost approach provides the best available indicator
`
`of the economic footprint of the '494 patent for
`
`purposes of evaluating the hypothetical negotiation
`
`in this case."
`
`THE COURT: But where does he say he rejects the
`
`Georgia-Pacific factors?
`
`MR. KAGAN: He doesn't. What he says is that they
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 13 of 138
`
` 13
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`would have a neutral impact on this, on his analysis.
`
`THE COURT: What would?
`
`MR. KAGAN: The Georgia-Pacific factors. So in other
`
`words, he has his cost approach. And he says: I've looked at
`
`the Georgia-Pacific factors, but they don't affect my
`
`analysis.
`
`So, he has his cost approach. And he says the
`
`Georgia-Pacific factors neither raise it nor lower it, so they
`
`have zero impact on his opinion. That's what he says.
`
`The second point which I think is dispositive as well is
`
`that in none of the sections of Mr. Arst's report that they
`
`have cited, and they want to include, does Mr. Arst do an
`
`apportionment of damages.
`
`And this is important because, as I think -- I think Mr.
`
`Andre, himself, personally argued the Blue Coat case on behalf
`
`of Finjan, where the Federal Circuit actually injected a -- a
`
`damages award where Finjan had failed to show apportionment of
`
`the damage.
`
`And this means when you have a product where all of the
`
`value is not derived from the patented invention -- now, that
`
`would obviously include the products in this case -- it is the
`
`plaintiff's burden to apportion and to say: This is the
`
`incremental value that is caused by the patent. Versus: This
`
`is the rest of the value that is attributable to other factors.
`
`Juniper's patents, other intellectual property, brand name,
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 14 of 138
`
` 14
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`et cetera.
`
`There's nothing in the cited sections of Mr. Arst's report
`
`that addresses the apportionment issue. And if Finjan cannot
`
`present apportionment testimony, they cannot present a damages
`
`case. Their damages case fails, as a matter of law.
`
`And assuming, given Mr. Andre's familiarity with the Blue
`
`Coat case, I don't think he would dispute that principle of
`
`law.
`
`THE COURT: "Blue" what?
`
`MR. KAGAN: Finjan versus Blue Coat.
`
`THE COURT: "Coat," like --
`
`MS. CARSON: C-O-A-T. Like a jacket (Indicating).
`
`THE COURT: Blue Coat. That says you have to
`
`apportion?
`
`MR. KAGAN: That, among other cases. It's applying
`
`another set of cases.
`
`But, you know, given the closeness and the familiarity of
`
`the counsel in this case with the Blue Coat case, I think it's
`
`-- it's very apt. And specifically, I can read a couple
`
`portions of the case if the Court --
`
`THE COURT: No, I understand the apportionment
`
`concept. But, look, did -- all right. We've had enough on
`
`this. I'm not going to make a ruling now.
`
`I may or may not allow Arst to testify. We will see. We
`
`have a trial coming on Monday. We're going to get ready for
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 15 of 138
`
` 15
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`it.
`
`You do have a problem. It is true, you swung for the
`
`fences and struck out. So that was the gamble you took. If
`
`you had won the gamble, it would have been a home run, maybe
`
`the World Series. But, God bless you for trying, but it was
`
`like Babe Ruth sometimes did hit a home run. He had more
`
`strikeouts than anybody at the time. But he also had a lot of
`
`home runs. This time you got a strikeout, at least in the
`
`District Court.
`
`But I am not prepared to say that -- you know, you
`
`big-firm people think that you've got to have an expert or you
`
`don't get damages. It's not quite true. You can present a
`
`damages case sometimes without an expert. It happens all the
`
`time in other kinds of cases.
`
`Is there a Federal Court -- a Federal Circuit decision
`
`somewhere that says if you don't have an expert, you get no
`
`damages? I doubt it.
`
`MR. KAGAN: There is not.
`
`MR. ANDRE: Just the opposite, Your Honor.
`
`THE COURT: So I feel like maybe Mr. Andre --
`
`sometimes -- Babe Ruth could come up again. Maybe he gets --
`
`get a second bite at the apple during the trial. Maybe he can
`
`ambush your guy. What's your guy's name? Rubin?
`
`MR. KAGAN: Ugone.
`
`THE COURT: Yeah. That guy. Maybe he will
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 16 of 138
`
` 16
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`cross-examine him so skillfully that the jury will award
`
`$70 million.
`
`MR. KAGAN: Your Honor, given that they're stuck with
`
`a $1.8 million base, I think that's unlikely.
`
`THE COURT: Yeah, I think so, too. But I'm -- that's
`
`why I enjoy this. Because he's going to get maybe a shot,
`
`shot to try.
`
`MR. KAGAN: Your Honor --
`
`THE COURT: No, I'm not going to be talked out of
`
`this. You're not going to just get to the end of the case
`
`because I exclude their expert. There's other ways to prove
`
`damages. And I'm not prepared to say he doesn't have a
`
`damages case at all.
`
`MR. KAGAN: I wasn't going to argue that. What I was
`
`going to ask, though, is if we could get a formal offer of
`
`proof --
`
`THE COURT: He has. He went through each section
`
`that he wants to prove.
`
`That's the offer of proof, right?
`
`MR. ANDRE: Your Honor, it is for Mr. Arst. That's
`
`what he will testify to. And Your Honor is absolutely
`
`correct. We will put on a fact-based case.
`
`I've tried several cases the last two days without a
`
`damages expert.
`
`THE COURT: That's good. Actually, it heartens me to
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 17 of 138
`
` 17
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`hear that. Because these experts are all bought and paid for.
`
`You don't have to admit it, but they are. And it's good to
`
`know that some lawyer, somewhere, can still try a case without
`
`an expert.
`
`MR. ANDRE: We've done it several times, Your Honor.
`
`And I personally prefer it. I know some courts don't like it,
`
`but I think it's the way we should do it in the future because
`
`I think these experts are --
`
`THE COURT: Bought and paid for. You don't have to
`
`say it.
`
`MR. ANDRE: Well, I won't say that, but --
`
`THE COURT: Okay. That's all I'm going to say on
`
`this subject for now. I may -- I've got to look at these
`
`sections and see if I think there is something coherent there,
`
`that, that the jury ought to -- so if you're going to put
`
`anything -- how many lawyers you got there? One, two, three
`
`four, five, six, seven lawyers at that table.
`
`So by 5:00 today, if you have anything to say on these
`
`subjects, these sections, it's due by 5:00 p.m. So one of
`
`those lawyers -- five of them, seven -- better get cracking if
`
`you want to explain why this is not a coherent thing.
`
`Okay. Now we have some other motions in limine that I
`
`want to take up. Let's start with the ones that are directed
`
`at the plaintiff's case.
`
`So Motion No. 1 to exclude evidence regarding Cyphort and
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 18 of 138
`
` 18
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`the ATP appliance product.
`
`So first let me ask Finjan to explain the relevance of
`
`whatever that testimony is, and then I'll get the other side to
`
`explain why it should be excluded.
`
`So give me your offer of proof on those subjects, and then
`
`why you think it's relevant. Go ahead.
`
`MS. KOBIALKA: So first and foremost, it's relevant
`
`because it goes to the issue of damages, and in particular,
`
`notice. Cyphort received specific notice regarding the '494
`
`patent which is at issue here, for the same class of products
`
`that we're talking about here. This is this ATP class of
`
`products. That knowledge is imputed to Juniper, who later
`
`then -- who acquired Cyphort.
`
`So first and foremost is it relates to the fact that they
`
`can't say -- and this is a disputed issue -- that they didn't
`
`know about the '494 patent, they were not aware that there were
`
`infringement allegations --
`
`THE COURT: Why do you say -- why would knowledge by
`
`Cyphort put Juniper on notice?
`
`MS. KOBIALKA: Because Juniper acquired Cyphort, and
`
`so that knowledge is imputed to Juniper.
`
`THE COURT: And when, when did that acquisition
`
`occur?
`
`MS. KOBIALKA: I believe it occurred in 2017.
`
`THE COURT: After the patent expired.
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 19 of 138
`
` 19
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`MS. KOBIALKA: That may be correct. That's correct.
`
`THE COURT: So you're saying that knowledge that was
`
`acquired after the patent expired can retroactively constitute
`
`notice for purposes of the marking statute?
`
`MS. KOBIALKA: Well, for purposes of the due
`
`diligence. The closing of the deal -- I mean, it takes a long
`
`time for these type of acquisitions to occur. And my
`
`understanding, the closing of the deal was after the patent
`
`expired. But the notification process had happened around the
`
`time that Juniper was actually doing the due diligence of
`
`Cyphort. So --
`
`THE COURT: So your theory is somebody going in there
`
`do due diligence to decide whether to buy Cyphort and seeing a
`
`letter in there from Finjan saying: You infringed the '494
`
`patent would have put the acquiring company on notice, even
`
`before the acquisition, that maybe the acquiring company's own
`
`product --
`
`MS. KOBIALKA: Well, this is in addition to the
`
`notice that we also provided to Juniper. So I'm not saying
`
`that fact, in and of itself. There is -- you know, this is a
`
`fact issue. Actual notice is a factual dispute that the jury
`
`can decide. And so this is part of that notice that was
`
`provided.
`
`There was additional conversations, direct conversations
`
`which were recorded --
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 20 of 138
`
` 20
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`THE COURT: What does the notice have to be? Under
`
`the statute, what does the law from the Federal Circuit say
`
`that the notice has to be?
`
`MS. KOBIALKA: There has to be an affirmative
`
`representation that -- of: This particular patent's infringed
`
`by the accused. And generally, it will require some
`
`identification of the technology at issue. So the
`
`functionality would be sufficient. If you identify the
`
`functionality --
`
`THE COURT: So then don't have you to have a letter
`
`from Finjan directly to Juniper saying: Your thing infringes?
`
`MS. KOBIALKA: Absolutely not.
`
`THE COURT: Say it again, then. I misunderstood what
`
`the statute requires.
`
`MS. KOBIALKA: So the statute just requires -- and
`
`the interpretations, the Berkheimer cases, from the Federal
`
`Circuit -- is just some affirmative representation. That can
`
`be by oral notice. It is not required to be written.
`
`There are other portions of the statute, for example, when
`
`you're dealing with a foreign entity under 271(g), where you
`
`are required written notice. But most instances, there is
`
`written notice. And that's why a lot of the cases talk about
`
`written notice.
`
`However, actual notice goes not require a writing. It can
`
`come in many different forms --
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 21 of 138
`
` 21
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`THE COURT: Actual notice of what, though?
`
`MS. KOBIALKA: Oh. Of the infringement of the
`
`patent.
`
`THE COURT: So it's not enough to know the patent
`
`exists. It has to be that your side thinks that it --
`
`accuses. Is that it?
`
`MS. KOBIALKA: Absolutely. So --
`
`THE COURT: But you don't have such a letter. You
`
`don't even have such a conversation, do you?
`
`MS. KOBIALKA: Yes, we do.
`
`THE COURT: What is your conversation?
`
`MS. KOBIALKA: The conversation took -- well, there
`
`was first notification about licensing the portfolio,
`
`February 9, 2017. The '494 patent wasn't specifically
`
`identified there.
`
`THE COURT: Was? Or was not?
`
`MS. KOBIALKA: Was not.
`
`THE COURT: Okay.
`
`MS. KOBIALKA: However, subsequently, there were
`
`discussions between John Garland who works for Finjan, and
`
`Scott Coonan, who works for Juniper, who is, I believe, their
`
`head of IP. And Mr. Coonan recorded these phone calls.
`
`In all the deposition testimony -- and I can quote that --
`
`the '494 was specifically identified. This class of products
`
`that ATP class of products, whether it's a box or if it's in
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 22 of 138
`
` 22
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`the cloud, was identified as infringing.
`
`And Mr. Garland --
`
`THE COURT: And this was in a phone call?
`
`MS. KOBIALKA: That was -- yes.
`
`THE COURT: Recorded.
`
`MS. KOBIALKA: It turns out Mr. Coonan recorded it,
`
`unbeknownst to us.
`
`THE COURT: So when we hear the recording it will say
`
`something like -- this is one that you want to exclude, I
`
`think.
`
`MS. KOBIALKA: (Nods head)
`
`THE COURT: But if the jury hears it, it would say
`
`something like: Oh, the '494. Oh, your ATP system infringes
`
`it.
`
`MS. KOBIALKA: Yeah. We think you need a license to
`
`the '494 patent in addition to these other ones.
`
`And in particular, the types of technologies that were at
`
`issue that they were talking about in that conversation.
`
`THE COURT: All right. So the statute -- you say
`
`that would be -- that, alone, would be enough to provide
`
`notice.
`
`When did that conversation occur?
`
`MS. KOBIALKA: November, 2015.
`
`THE COURT: And what is our damages period here?
`
`MS. KOBIALKA: It ends January 29, 2017.
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 23 of 138
`
` 23
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`THE COURT: And when does it begin.
`
`MS. KOBIALKA: Issued in 2014. I think March, 2014.
`
`THE COURT: What issue?
`
`MS. KOBIALKA: The patent at issue. The '494 patent.
`
`THE COURT: Okay. How come it's such a short patent?
`
`MS. KOBIALKA: This particular patent -- oh, the
`
`priority goes way back. It is a continuation of some earlier
`
`patent.
`
`THE COURT: Okay.
`
`MS. KOBIALKA: And I think there was a number of
`
`challenges to it over time, but it withstood all those
`
`changes.
`
`THE COURT: All right. 2014 to when, 2017?
`
`MS. KOBIALKA: I have the exact date. March 18, 2014
`
`through January -- I believe it's 29, 2017.
`
`THE COURT: And that's the damages period.
`
`MS. KOBIALKA: Yes.
`
`THE COURT: And when did this phone call take place?
`
`MS. KOBIALKA: November, 2015.
`
`THE COURT: All right. So, let's just pause right
`
`there for a second.
`
`I want to hear from the other side on the phone call, and
`
`why that would not have been enough notice, and what does the
`
`statute require for notice and so forth.
`
`Go ahead.
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 24 of 138
`
` 24
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`MS. CARSON: Well, Your Honor, the Federal Circuit
`
`has found that what is required for the notice is that there's
`
`an affirmative communication to the alleged infringer of a
`
`specific charge of infringement by a specific accused product
`
`or device.
`
`So Finjan is trying to broaden this requirement or to
`
`loosen this requirement to not require the identification of a
`
`specific accused product or device.
`
`Whether in oral or written notice, Finjan never identified
`
`Sky ATP or SRX used in combination with Sky ATP.
`
`THE COURT: I'm sorry; your name, again, is what?
`
`MS. KOBIALKA: Kobialka. Lisa Kobialka.
`
`THE COURT: Can -- do I have a list? Is this --
`
`where's my list?
`
`(Off-the-Record discussion between the Court and Clerk)
`
`THE COURT: Oh, here we go. "Kobialki."
`
`MS. KOBIALKA: Kobialka. Yes.
`
`THE COURT: And your name over there is --
`
`MS. CARSON: Ms. Carson.
`
`THE COURT: Sorry, I just don't see -- would you
`
`highlight it on here? I can't find the names on there.
`
`(Document handed down)
`
`THE COURT: Okay. There's so much information, I
`
`can't find what I need.
`
`All right. So, Ms. K -- K-o-b, and I'll get it right in a
`
`
`
`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 25 of 138
`
` 25
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`minute; I apologize -- says you don't need to have what you
`
`just told me. That you're -- you're amplifying on what's
`
`required. She said that the telephone call identified your
`
`product, said you needed a license.
`
`What, what am I missing?
`
`MS. CARSON: Well, Your Honor, I think she is not
`
`accurately describing what occurred during the phone call.
`
`Mr. Gardner never specifically identified Sky ATP. The only
`
`product that he specifically mentioned was the SRX.
`
`And they have not ac